Page 8 - தடிப்புத்+தோல்+அழற்சி நோயாளிகள் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from தடிப்புத்+தோல்+அழற்சி நோயாளிகள். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In தடிப்புத்+தோல்+அழற்சி நோயாளிகள் Today - Breaking & Trending Today

8 Penyebab Bentol Merah di Kaki dan Cara Mengatasinya

8 Penyebab Bentol Merah di Kaki dan Cara Mengatasinya
liputan6.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from liputan6.com Daily Mail and Mail on Sunday newspapers.

Cause Bump Red , Way Overcome , Skin Cancer , தோல் புற்றுநோய் ,

Novel non-steroid topical cream can safely and effectively treat plaque psoriasis


Novel non-steroid topical cream can safely and effectively treat plaque psoriasis
Psoriasis is a chronic inflammatory skin disease characterized by erythematous (red) patches and plaques. In some patients, psoriasis may be associated with comorbidities such as arthritis, obesity, diabetes, cardiovascular diseases, hyperlipidemia, or depression. Psoriasis lesions can occur on the scalp and face, in addition to all other areas of the body, causing considerable physical discomfort and psychosocial trauma from the stigma surrounding appearance defects.
More than 90% of patients with psoriasis have what is called psoriasis vulgaris, which is characterized by plaques, and less than 5% have the other varieties: arthritic psoriasis, pustular psoriasis, and erythrodermic psoriasis. The most common treatments for mild to moderate plaque psoriasis are topical corticosteroids and vitamin D3 analogs. ....

Jian Zhong Zhang , Genhui Chen , Wenfeng Tianji Pharma , Emily Henderson , University People Hospital , Chinese Medical Journal , Peking University People , Beijing Wenfeng Tianji , ஜியான் ஜாங் ஜாங் , எமிலி ஹென்டர்சன் , பல்கலைக்கழகம் மக்கள் மருத்துவமனை , சீன மருத்துவ இதழ் , பேகிங் பல்கலைக்கழகம் மக்கள் , நீரிழிவு நோய் , உடல் பருமன் ,

Low fitness linked to higher psoriasis risk later in life


University of Gothenburg
In a major register-based study, scientists at the University of Gothenburg, Sweden, have now demonstrated a connection between inferior physical fitness in young adults and elevated risk of the autoimmune disease psoriasis. For the male recruits to compulsory military training who were rated as the least fit, the risk of developing psoriasis later was 35 per cent higher than for the fittest.
The study was based on data on more than 1.2 million men conscripted, aged 18, into the Swedish Armed Forces between the years 1968 and 2005. During the enrollment process, all these young men underwent the same fitness test on an exercise bicycle. The researchers divided the data, according to how fit the men were, into three levels (low, medium, and high fitness). They then merged the data with other registers, using Sweden’s National Patient Register to obtain diagnostic codes for psoriasis and the joint disease psoriatic arthritis. The men who had alrea ....

Vastra Gotalands Lan , Marta Laskowski , Sahlgrenska University Hospital , Swedish Armed , University Of Gothenburg , Sweden National Patient Register , Swedish Armed Forces , National Patient Register , Sahlgrenska University , Autoimmune Disease , Young Adults , Health Care , மார்த்தா லாஸ்கோவ்ஸ்கி , ஸ்விட்ச் ஆயுதம் , பல்கலைக்கழகம் ஆஃப் கோடெந்ப்ர்க் , ஸ்வீடந் தேசிய நோயாளி பதிவு , ஸ்விட்ச் ஆயுதம் படைகள் , தேசிய நோயாளி பதிவு , ஆட்டோ இம்யூன் நோய் , ஆரோக்கியம் பராமரிப்பு ,

UNION therapeutics A/S receives FDA approval for IND of oral next generation PDE4-inhibitor (orismilast) for investigation in plaque psoriasis


(1)
- Orismilast is a next generation oral PDE4-inhibitor with an improved therapeutic window compared to other PDE4-inhibitors
- Oral orismilast (UNI50001) has demonstrated proof of concept in patients living with plaque psoriasis and indicated best-in-class potential
- PDE4-inhibition is a validated pharmacological target published for a broad range of inflammatory indications
1
- The improved therapeutic window of orismilast suggests potential for use in a number of inflammatory conditions, which have so far been limited by the typical narrow therapeutic window of PDE4-inhibitors
HELLERUP, Denmark, Jan. 7, 2021 /PRNewswire/ UNION therapeutics A/S (UNION) today announces that the US Food and Drug Administration (FDA) has approved an Investigational New Drug program (IND) for oral orismilast; a next generation PDE4-inhibitor for the treatment of plaque psoriasis in adults. ....

Marie Louise Jersin , Kostenloser Wertpapierhandel , Morten Boesen , Morten Sommer , Kim Domela Kjoeller , Drug Administration , Szpirt Company , Investigational New Drug , Professor Morten , Not So Common Comorbidities , Semin Cutan Med , மார்டந் போஸன் , மார்டந் சோமர் , ப்ரொஃபெஸர் மார்டந் ,